We aim to turn science into intellectual property rights for technology transfer and would like to invite potential business / R&D partners to express their interests on the following R&D projects:

Expression of Interests for Licensing & Cooperation:

1. JCM-01021 – Myocardial Ischemia
2. JCM-01022 – Hyperlipidemia
3. JCM-01023 – Myocardial Ischemia
4. JCM-06021 – Rheumatoid Arthritis
5. JCM-16021 – Irritable Bowel Syndrome
6. JCM-19021 – Modulation of Blood Glucose
7. JCM-26021 – Menopausal Women Health
8. JCM-39021 – Anti-Depression
9. JCM-02021 – Anti-tussive Agent
10. JCM-01031 – Novel Compound with Anti-Cancer Bio-activities
11. JCM-01032 – Novel Compounds from Fructus Psoraleae for Drug Development & QC
12. JCM-2-02R – DNA and Chemical Technologies for Authentication & Assessment of Chinese Medicinal Materials

For other inquiries on business opportunities, please contact business@hkjcicm.org

Download Brochure

Incubation Model
R&D Portfolio

Our Business Model
Express of Interest
IP Guidelines